Page 2903 - Company News

Telecom a force-multiplier for all sectors, is an essential service: COAI

Telecom sector with transformational powers is set to be a force-multiplier for other sectors, and the government needs to view it as an essential service and enabler for industries, COAI said

Gujarat: Tanishq store puts up apology note after furore over withdrawn ad

A Tanishq showroom in Gandhidham town of Gujarat's Kutch district has put up a note on its door, apologising to Hindus in the district over the brand's controversial TV ad which was withdrawn

Alstom's e-locos approved for freight locomotives to run at 120 kmph

Electric locos allow heavy freight trains to haul 6,000 tonnes at a top speed of 120 kmph and they are expected to increase the average speed by at least 20-25 kmph

Housing sales may increase by 35% in Oct-Dec on festive demand: Report

The coming festive season is likely to witness a surge in demand for residential properties and the housing sales may rise 35 per cent across the top 7 cities during the Oct-Dec period on a QoQ basis

Mercedes-Benz reports 38% drop in sales at 2,058 units in India for Q3

German luxury car maker Mercedes-Benz reported a 38.64 per cent drop in its sales at 2,058 units in India in the third quarter of the ongoing year but almost reached its pre-Covid sales level

Amazon opens largest fulfilment centre in Bengal ahead of festive season

The facility has a capacity of 1.2 mn cubic ft; firm triples storage at an existing centre for large appliances and furniture to 600,000 cubic ft

Airports see uptick in retail sales, line up sweeteners for passengers

Bengaluru airport in process of finalisng new brands for its retail and F&B zone

Covid-19 impact: CRISIL downgrades Thomas Cook India's rating to A+

The ratings are a result of the pandemic weakening the company's business and financial risk profiles

Glenmark Pharma launches pulmonary fibrosis treatment drug in India

Glenmark Pharma announced the launch of its generic version of Nintedanib (NINDANIB), used for the treatment of pulmonary fibrosis, in India

Infosys Q2 preview: Large deal wins to drive revenue growth, say analysts

Edelweiss Securities expects revenue to grow 3.9 per cent QoQ in constant currency terms and 5.4 per cent QoQ in US dollar terms.

Bharat Dynamics Limited pays final dividend of Rs 35 crore to government

Bharat Dynamics Limited, a Hyderabad based Defence Public Sector Undertaking has paid final dividend of Rs 35.018 crore to the government of India

Vodafone case shows why India's not renewing 70-odd BITs with foreign govts

India does not recognise the jurisdiction of any foreign court in a commercial dispute that questions the state's sovereign power to intervene

Tanishq's oneness ad bares divide after firm succumbs to pressure

There are lessons in the controversy; brand should have held its ground: Analysts

Reliance Jio continues to remain the fastest mobile network: Trai

Vodafone recorded the highest speed in terms of upload in September, according to the latest data from the telecom regulator

JSW to raise $1 bn from overseas, domestic markets to retire debt

The company has also agreed to acquire Bhushan Power and Steel for Rs 19,700 crore and has kept the funds ready for the acquisition

Food delivery volumes back to 85% of pre-Covid levels, says Swiggy

The recovery is taking place owing to multiple rounds of unlocks and restaurants opening up for business.

Buybacks for FY21 cross last yr's tally after announcements from TCS, Wipro

Change in tax structure leads to revival of share repurchase programmes

Vedanta to return $2.5 billion funds after delisting plan fails: Report

Vedanta Resources Ltd will repay $1.4 billion raised via bonds and another $1.1 billion in loans, with a small amount of interest, as early as this week

Tepid response to Federal Mogul OFS, bids received for less than 10% shares

Market participants said high valuation and low liquidity at the counter was behind the poor response

GSK Pharma's growth challenges to remain in near term as Covid dents sales

Even as overall pharma market was up 5% over the year-ago period, GSK's September sales were down 8%, the firm is banking on recovery led by top brands, new launches